EX-99.1 2 uht-ex99_1.htm EX-99.1 EX-99.1

 

 

第99.1展示文本

 

通用健康房地產收入信託

 

 

通用企業中心

 

 

 

 

367 號古爾夫路

 

 

 

 

郵政信箱 61558 號

 

 

 

 

King of Prussia, PA 19406

 

 

 

 

(610) 265-0688

 

立即發佈

聯繫人:

 

Charles Boyle

 

2024年10月24日

 

 

首席財務官

 

 

 

 

(610) 768-3300

 

 

通用健康房地產收入信託

2024年第三季度財務報告

2024年和2023年截至9月30日三個月的綜合經營結果:

賓夕法尼亞州金斯普雷西亞 - 紐交所上市的universal health realty income trust(NYSE:UHT)今天宣佈,截至2024年9月30日的三個月內,淨利潤爲400萬美元,每股攤薄收益爲0.29美元,相比2023年第三季度的390萬美元,每股攤薄收益爲0.28美元。

與2023年第三季度相比,截至2024年9月30日三個月期間,我們的淨利潤增加了125,000美元,每股稀釋股份爲0.01美元,主要由以下部分組成:(i)由於各處產生的收入淨增加總額增加了451,000美元,每股稀釋股份爲0.03美元,部分被部分抵消; (ii)由於我們平均未償還債務增加和平均借款利率略有增加,導致利息支出增加,減少了326,000美元,每股稀釋股份減少0.02美元。

根據附表中的非GAAP補充信息表(「補充表」)計算,我們的所有基金類型運營資金(「FFO」)爲1130萬美元,每股攤薄後爲0.82美元,在2024年第三季度,而在2023年第三季度爲1120萬美元,每股攤薄後爲0.81美元。每股攤薄後增加了124,000美元,即0.01美元,主要是因爲我們在2024年第三季度的淨利潤較2013年第三季度有所增加。

2024年和2023年截至9月30日的合併業績結果:

2024年9月30日結束的九個月淨利潤爲1460萬美元,每股稀釋收益爲1.05美元,相較於2023年頭九個月的1180萬美元,每股稀釋收益爲0.85美元。

2024年前九個月我們的淨利潤增加了280萬美元,每股稀釋後收益爲0.20美元,相比於2023年同期,主要包括以下內容:(i) 來自不同物業產生的收入總額淨增長導致淨增加了250萬美元,每股稀釋後收益爲0.18美元;(ii) 源於位於伊利諾伊州芝加哥的物業相關費用減少,包括來源於2023年前九個月拆除費用的110萬美元和2024年前九個月記錄的房產稅減免造成的563,000美元,主要涉及較以往期間的部分,部分抵消;(iii) 由於2024年前九個月的增加,導致減少了160萬美元,每股稀釋後收益爲0.11美元。

 


 

 

利息支出增加主要是由於我們的平均借款利率和平均未償借款增加。

根據附表中的計算,我們的FFO在2024年前九個月爲3610萬美元,每股稀釋後爲2.61美元,而在2023年同期爲3320萬美元,每股稀釋後爲2.40美元。每股稀釋後增加了290萬美元,或0.21美元,主要是由於2024年前九個月我們的淨利潤增加,相比於2023年前九個月。

股息信息:

2024年9月4日宣佈每股派息0.73美元,總計金額爲1010萬美元,於2024年9月30日支付。

資金資源信息:

2024年9月30日,我們簽訂了第二份修訂和重新訂立的信貸協議,將借款額度提高到42500萬美元(之前爲37500萬美元),並將到期日延長至2028年9月30日(之前爲2025年7月)。我們有權將到期日延長至最多兩個額外的六個月期限。

截至2024年9月30日,根據我們的42500萬美元循環信貸協議條款,我們有34780萬美元的未償債務,截至該日期,扣除未償債務後,可借額度爲7720萬美元。

Sierra 醫療廣場 I:

2023年3月,位於內華達州雷諾的Sierra醫療廣場I的建設基本完成,面積爲86,000平方英尺,位於北內華達州Sierra醫療中心的校園內。這家醫院是UHS全資子公司擁有和經營的,在2022年4月完成並開業。與這座建築有關的主力靈活租賃協議始於2023年3月,爲期十年,到期日定於2033年3月31日,涵蓋MOb可租用平方英尺的約68%,起始最低租金爲每年130萬美元,加上按比例分攤的公共區域維護費用。這項主力靈活租賃協議將根據第三方租約的簽訂而進行調整。 MOb的總成本估計約爲3500萬美元,其中截至2024年9月30日爲止,約3000萬美元已支出。

空地/專業設施:

2023年完成了位於伊利諾伊州芝加哥的前專科醫院的拆除工作。總拆除費用約爲150萬美元(其中110萬美元發生在2023年第一和第二季度,33.2萬美元發生在2022年第四季度)。此外,2023年12月,我們出售了位於德克薩斯州科珀斯克里斯蒂的空置專科設施。

我們繼續營銷位於芝加哥、伊利諾伊州和印第安納州埃文斯維爾的空置物業。未來與這些物業相關的營業費用,在這些物業保持所有權且未出租期間將由我們承擔。

金融工具:

2024年10月,我們與一家利率互換協議,協議的名義總額爲8500萬美元,並規定固定利率爲3.2725%,作爲現金流量套期保值。該利率互換協議於2024年10月2日生效,預計於2028年9月30日到期。如果一個月期SOFR高於3.2725%,對方將支付給我們,如果一個月期SOFR低於

 


 

 

我們支付與對手方之間的差額,該差額由3.2725%的固定利率和一個月期限的SOFR之間的差額組成。

此利率互換協議取代了兩項利率互換協議,其在2024年9月16日到期,合計名義金額爲8500萬美元。

一般信息、前瞻性聲明和風險因素以及非GAAP財務指標:

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-six properties located in twenty-one states.

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7 - Forward-Looking Statements in our Form 10-K for the year ended December 31, 2023 and in Item 7 - Forward-Looking Statements and Certain Risk Factors in our Form 10-Q for the quarter ended June 30, 2024), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the shortage of nurses and other clinical staff and support personnel, the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions related to supplies required for our tenants’ employees and patients; and potential increases to other expenditures.

In addition, the increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.

We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains on transactions.

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by

 


 

 

the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of certain items, such as gains or losses on transactions that occurred during the periods presented. FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.

To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2023 and our Report on Form 10-Q for the quarter ended June 30, 2024. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

 

(more)

 


 

 

Universal Health Realty Income Trust

Consolidated Statements of Income

For the Three and Nine Months Ended September 30, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

  Lease revenue - UHS facilities (a.)

 

$

8,248

 

 

$

8,274

 

 

$

25,366

 

 

$

24,297

 

  Lease revenue - Non-related parties

 

 

14,342

 

 

 

13,926

 

 

 

43,188

 

 

 

40,955

 

  Other revenue - UHS facilities

 

 

242

 

 

 

254

 

 

 

682

 

 

 

730

 

  Other revenue - Non-related parties

 

 

305

 

 

 

404

 

 

 

1,056

 

 

 

1,177

 

  Interest income on financing leases - UHS facilities

 

 

1,357

 

 

 

1,365

 

 

 

4,077

 

 

 

4,096

 

 

 

 

24,494

 

 

 

24,223

 

 

 

74,369

 

 

 

71,255

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

  Depreciation and amortization

 

 

7,009

 

 

 

7,012

 

 

 

20,624

 

 

 

20,479

 

  Advisory fees to UHS

 

 

1,386

 

 

 

1,332

 

 

 

4,093

 

 

 

3,957

 

  Other operating expenses

 

 

7,609

 

 

 

7,854

 

 

 

22,115

 

 

 

23,625

 

 

 

 

16,004

 

 

 

16,198

 

 

 

46,832

 

 

 

48,061

 

Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense

 

 

8,490

 

 

 

8,025

 

 

 

27,537

 

 

 

23,194

 

  Equity in income of unconsolidated LLCs

 

 

300

 

 

 

314

 

 

 

956

 

 

 

953

 

  Interest expense, net

 

 

(4,793

)

 

 

(4,467

)

 

 

(13,920

)

 

 

(12,340

)

Net income

 

$

3,997

 

 

$

3,872

 

 

$

14,573

 

 

$

11,807

 

Basic earnings per share

 

$

0.29

 

 

$

0.28

 

 

$

1.06

 

 

$

0.86

 

Diluted earnings per share

 

$

0.29

 

 

$

0.28

 

 

$

1.05

 

 

$

0.85

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding - Basic

 

 

13,807

 

 

 

13,790

 

 

 

13,799

 

 

 

13,784

 

Weighted average number of shares outstanding - Diluted

 

 

13,849

 

 

 

13,822

 

 

 

13,835

 

 

 

13,811

 

 

(a.) Includes bonus rental on McAllen Medical Center, a UHS acute care hospital facility, of $765 and $725 for the three-month periods ended September 30, 2024 and 2023, respectively, and $2,306 and $2,219 for the nine-month periods ended September 30, 2024 and 2023, respectively.

 

 

 

 


 

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)

For the Three Months Ended September 30, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)

 

Calculation of Adjusted Net Income

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

September 30, 2024

 

 

September 30, 2023

 

 

 

Amount

 

 

Per
Diluted Share

 

 

Amount

 

 

Per
Diluted Share

 

Net income

 

$

3,997

 

 

$

0.29

 

 

$

3,872

 

 

$

0.28

 

Adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Subtotal adjustments to net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjusted net income

 

$

3,997

 

 

$

0.29

 

 

$

3,872

 

 

$

0.28

 

 

Calculation of Funds From Operations (“FFO”)

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

September 30, 2024

 

 

September 30, 2023

 

 

 

Amount

 

 

Per
Diluted Share

 

 

Amount

 

 

Per
Diluted Share

 

Net income

 

$

3,997

 

 

$

0.29

 

 

$

3,872

 

 

$

0.28

 

Plus: Depreciation and amortization expense:

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated investments

 

 

7,009

 

 

 

0.51

 

 

 

7,012

 

 

 

0.51

 

Unconsolidated affiliates

 

 

311

 

 

 

0.02

 

 

 

309

 

 

 

0.02

 

FFO

 

$

11,317

 

 

$

0.82

 

 

$

11,193

 

 

$

0.81

 

Dividend paid per share

 

 

 

 

$

0.730

 

 

 

 

 

$

0.720

 

 

 

 


 

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)

For the Nine Months Ended September 30, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)

 

Calculation of Adjusted Net Income

 

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2024

 

 

September 30, 2023

 

 

 

Amount

 

 

Per
Diluted Share

 

 

Amount

 

 

Per
Diluted Share

 

Net income

 

$

14,573

 

 

$

1.05

 

 

$

11,807

 

 

$

0.85

 

Adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Subtotal adjustments to net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjusted net income

 

$

14,573

 

 

$

1.05

 

 

$

11,807

 

 

$

0.85

 

 

Calculation of Funds From Operations (“FFO”)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2024

 

 

September 30, 2023

 

 

 

Amount

 

 

Per
Diluted Share

 

 

Amount

 

 

Per
Diluted Share

 

Net income

 

$

14,573

 

 

$

1.05

 

 

$

11,807

 

 

$

0.85

 

Plus: Depreciation and amortization expense:

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated investments

 

 

20,624

 

 

 

1.49

 

 

 

20,479

 

 

 

1.48

 

Unconsolidated affiliates

 

 

918

 

 

 

0.07

 

 

 

900

 

 

 

0.07

 

FFO

 

$

36,115

 

 

$

2.61

 

 

$

33,186

 

 

$

2.40

 

Dividend paid per share

 

 

 

 

$

2.185

 

 

 

 

 

$

2.155

 

 


 

 

Universal Health Realty Income Trust

Consolidated Balance Sheets

(amounts in thousands, except share information)

(unaudited)

 

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Assets:

 

 

 

 

 

 

Real Estate Investments:

 

 

 

 

 

 

Buildings and improvements and construction in progress

 

$

654,154

 

 

$

649,374

 

Accumulated depreciation

 

 

(280,859

)

 

 

(262,449

)

 

 

 

373,295

 

 

 

386,925

 

Land

 

 

56,870

 

 

 

56,870

 

               Net Real Estate Investments

 

 

430,165

 

 

 

443,795

 

Financing receivable from UHS

 

 

82,921

 

 

 

83,279

 

               Net Real Estate Investments and Financing receivable

 

 

513,086

 

 

 

527,074

 

Investments in limited liability companies ("LLCs")

 

 

14,260

 

 

 

9,102

 

Other Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

 

6,372

 

 

 

8,212

 

Lease and other receivables from UHS

 

 

6,995

 

 

 

6,180

 

Lease receivable - other

 

 

8,580

 

 

 

8,166

 

Intangible assets (net of accumulated amortization of $11.9 million and
   $12.5 million, respectively)

 

 

7,758

 

 

 

9,110

 

Right-of-use land assets, net

 

 

10,925

 

 

 

10,946

 

Deferred charges, notes receivable and other assets, net

 

 

16,354

 

 

 

17,579

 

               Total Assets

 

$

584,330

 

 

$

596,369

 

Liabilities:

 

 

 

 

 

 

Line of credit borrowings

 

$

347,750

 

 

$

326,600

 

Mortgage notes payable, non-recourse to us, net

 

 

19,662

 

 

 

32,863

 

Accrued interest

 

 

736

 

 

 

490

 

Accrued expenses and other liabilities

 

 

12,690

 

 

 

13,500

 

Ground lease liabilities, net

 

 

10,925

 

 

 

10,946

 

Tenant reserves, deposits and deferred and prepaid rents

 

 

10,928

 

 

 

11,036

 

               Total Liabilities

 

 

402,691

 

 

 

395,435

 

Equity:

 

 

 

 

 

 

Preferred shares of beneficial interest,
   $.01 par value; 5,000,000 shares authorized;
   none issued and outstanding

 

 

-

 

 

 

-

 

Common shares, $.01 par value;
   95,000,000 shares authorized; issued and outstanding: 2024 - 13,849,424;
   2023 - 13,823,899

 

 

138

 

 

 

138

 

Capital in excess of par value

 

 

270,826

 

 

 

270,398

 

Cumulative net income

 

 

840,634

 

 

 

826,061

 

Cumulative dividends

 

 

(933,216

)

 

 

(902,975

)

Accumulated other comprehensive income

 

 

3,257

 

 

 

7,312

 

     Total Equity

 

 

181,639

 

 

 

200,934

 

               Total Liabilities and Equity

 

$

584,330

 

 

$

596,369